Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Sleep apnea does not go away on its own, although some of the conditions and structural factors that cause it can be treated and reversed. For instance, a septoplasty can fix a deviated septum that is ...

Additionally, the company successfully expanded its operations by adding new sales territories and implant centers ... with obstructive sleep apnea. It offers inspire therapy, which consists ...

Nearly 1 in 5 women and more than one-third of men in the United States have sleep apnea. This common sleep ... cases a surgical device called Inspire (hypoglossal nerve surgery) can be implanted.

Sleep apnea is a disorder that happens when your breathing is disrupted while you sleep. The condition affects sleep quality -- and it can also affect your pocketbook. An analysis by the American ...

Inspire is dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea. Disclaimer: This is an AI-generated summary of a press ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary ...